Alkermes (ALKS) Gets a Hold from J.P. Morgan | Markets Insider

Oct 26, 2024 · J.P. Morgan analyst Jessica Fye maintained a Hold rating on Alkermes (ALKS – Research Report) yesterday and set a price target of $26.00. The company’s shares closed …

CouponFollow Extension

$26.00
OFF

Alkermes (ALKS) Gets A Hold From J.P. Morgan | Markets Insider

1 week from now

Oct 26, 2024 · J.P. Morgan analyst Jessica Fye maintained a Hold rating on Alkermes (ALKS – Research Report) yesterday and set a price target of $26.00. The company’s shares closed …

businessinsider.com

$32.00
OFF

Alkermes (ALKS) Receives A Hold From J.P. Morgan - Markets Insider

1 week from now

Jul 29, 2024 · In a report released on July 25, Jessica Fye from J.P. Morgan maintained a Hold rating on Alkermes (ALKS – Research Report), with a price target of $32.00.The company’s …

businessinsider.com

$33.00
OFF

Decoding 5 Analyst Evaluations For Alkermes | Markets Insider

1 week from now

Jan 2, 2024 · Analysts' ratings for Alkermes (NASDAQ:ALKS) over the last quarter vary from bullish to bearish, as provided by 5 analysts. ... JP Morgan: Announces: Neutral: $33.00- ...

businessinsider.com

$22.06
OFF

Alkermes' (ALKS) Overweight Rating Reiterated At Piper Sandler

1 week from now

Oct 25, 2024 · Alkermes has a 52 week low of $22.06 and a 52 week high of $32.88. The stock has a market cap of $4.41 billion, a PE ratio of 10.44, a PEG ratio of 0.56 and a beta of 0.46. …

marketbeat.com

$35.42
OFF

Alkermes (ALKS) Stock Forecast And Price Target 2024 - MarketBeat

1 week from now

3 days ago · According to the 12 analysts' twelve-month price targets for Alkermes, the average price target is $35.42. The highest price target for ALKS is $50.00, while the lowest price …

marketbeat.com

$28.87
OFF

ALKS Stock Quote, News, And History - Markets Insider

1 week from now

4 days ago · On Friday 11/08/2024 the closing price of the Alkermes PLC share was $28.87 on BTT. Compared to the opening price on Friday 11/08/2024 on BTT of $29.05, this is a drop of …

businessinsider.com

64%
OFF

Is Alkermes (ALKS) The Most Undervalued Quality Stock ... - Insider …

1 week from now

Oct 12, 2024 · Alkermes (NASDAQ: ALKS) Average Upside Potential: 15.64%. Forward Price-to-Earnings Ratio: 13.48. Number of Hedge Fund Holders: 32. Alkermes (NASDAQ:ALKS) …

insidermonkey.com

42%
OFF

Alkermes Plc (ALKS) Stock Price, News, Quote & History - Yahoo …

1 week from now

0.0900. +18.42%. Find the latest Alkermes plc (ALKS) stock quote, history, news and other vital information to help you with your stock trading and investing.

yahoo.com

3%
OFF

Alkermes Plc (NASDAQ:ALKS) Shares Sold By Principal

1 week from now

3 days ago · November 13, 2024. Principal Financial Group Inc. cut its position in shares of Alkermes plc (NASDAQ:ALKS - Free Report) by 7.3% during the third quarter, according to its …

marketbeat.com

41%
OFF

Alkermes (ALKS) Stock Dips While Market Gains: Key Facts

1 week from now

Feb 1, 2024 · Alkermes (ALKS) closed at $26.94 in the latest trading session, marking a -0.41% move from the prior day. This change lagged the S&P 500's daily gain of 1.25%. On the other …

nasdaq.com

93%
OFF

Alkermes (ALKS) Outpaces Stock Market Gains: What You Should …

1 week from now

Jan 12, 2024 · Alkermes (ALKS) closed the most recent trading day at $28.20, moving +0.93% from the previous trading session. The stock's change was more than the S&P 500's daily gain …

nasdaq.com

$21
OFF

ALKS - Alkermes Plc Stock Price And Quote - FINVIZ.com

1 week from now

UBS Adjusts Price Target on Alkermes to $21 From $23, Maintains Sell Rating. (MT Newswires) 07:00AM. Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk. (PR …

finviz.com

$25.00
OFF

Alkermes (ALKS) Gets A Hold From Stifel Nicolaus - Markets Insider

1 week from now

Oct 28, 2024 · Stifel Nicolaus analyst Paul Matteis maintained a Hold rating on Alkermes (ALKS – Research Report) on October 25 and set a price target of $25.00. The company’s shares …

businessinsider.com

FAQs about Alkermes (ALKS) Gets a Hold from J.P. Morgan | Markets Insider Coupon?

Should you Buy FYE & Alkermes (AlkS)?

According to TipRanks, Fye has an average return of 6.2% and a 52.71% success rate on recommended stocks. In addition to J.P. Morgan, Alkermes also received a Hold from Bank of America Securities’s Jason Gerberry in a report issued yesterday. However, on the same day, Goldman Sachs maintained a Buy rating on Alkermes (NASDAQ: ALKS). ...

What is Alkermes's price target?

This current average represents a 3.18% decrease from the previous average price target of $33.67. A clear picture of Alkermes's perception among financial experts is painted with a thorough analysis of recent analyst actions. ...

What is Alkermes plc's market capitalization?

Alkermes PLC's market capitalization is $4.35 B by 164.67 M shares outstanding. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Selling, General & Admin. Exp. * Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet Income Statements in Mio. USD ...

How do analysts evaluate Alkermes (Alkermes)?

Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Alkermes compared to the broader market. Price Targets: Understanding forecasts, analysts offer estimates for Alkermes's future value. ...

What is AlkS - Alkermes plc?

ALKS - Alkermes plc - Stock screener for investors and traders, financial visualizations. ...

How does Alkermes make money?

Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. ...